| Varsha S Gadgil, | |
|
1885 Bay Rd Ste A, East Palo Alto, CA 94303-1312 | |
| (650) 330-7457 | |
| Not Available |
| Full Name | Varsha S Gadgil |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1885 Bay Rd Ste A, East Palo Alto, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376630657 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 49108 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Varsha S Gadgil, 11626 Cedar Spring Ct, Cupertino, CA 95014-5139 Ph: (408) 805-9463 | Varsha S Gadgil, 1885 Bay Rd Ste A, East Palo Alto, CA 94303-1312 Ph: (650) 330-7457 |
News Archive
The U.S. Centers for Disease Control and Prevention estimate that well over one million people in the United States are infected with HIV/AIDS. New research from North Carolina State University shows that many of those infected are minorities and do not have health insurance, and highlights the need for a national strategy to facilitate education and prevention efforts in minority and low-income populations.
Cornerstone Therapeutics Inc., a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today announced that its product candidate CRTX-067 is an ANDA filing for a generic 10 mg chlorpheniramine polistirex/8 mg hydrocodone polistirex suspension product that will be a generic substitute for the product currently sold under the Tussionex brand name by UCB, Inc.
Today the Indoor Tanning Association (ITA) denounced Introduced Resolution 1714, which would ban Suffolk teens under the age of 18 from using a sun-bed.
Impax Laboratories, Inc. today confirmed that the U.S. Food and Drug Administration (FDA) has granted tentative approval of the Company's Abbreviated New Drug Application (ANDA) for generic version of FLOMAX® (tamsulosin hydrochloride) 0.4mg capsules. Boehringer Ingelheim Pharmaceuticals, Inc. markets FLOMAX® for the functional symptoms of benign prostatic hyperplasia.
Pfizer Inc. announced today the suspension of the osteoarthritis clinical program for the investigational compound tanezumab following a request by the U.S. Food and Drug Administration. The worldwide suspension – which is effective immediately – follows a small number of reports of tanezumab patients experiencing the worsening of osteoarthritis leading to joint replacement.
› Verified 9 days ago
Minh Nguyen Dang, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1775 E Bayshore Rd, East Palo Alto, CA 94303 Phone: 650-325-2018 | |
Arthur Herbert Lim, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2111 University Ave, East Palo Alto, CA 94303 Phone: 650-321-1449 Fax: 650-321-5977 | |
Soo Ah Kwon, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1775 E Bayshore Rd, East Palo Alto, CA 94303 Phone: 650-325-2018 | |
Kristy Mai Nishikawa, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1885 Bay Rd, East Palo Alto, CA 94303 Phone: 650-617-7834 |